Skip to main content

Table 3 Ontology enrichment of proteomics data

From: Abnormal molecular signatures of inflammation, energy metabolism, and vesicle biology in human Huntington disease peripheral tissues

Dataset

Pathways

1: WikiPathways 2019 (human)

2: KEGG 2019 (human)

Ontology

[biological process]

Regulators

1: ChEA 2016

2: TTRUST 2019

3: ENCODE 2015

Adipose:

early-HD vs. control

1: Blood clotting cascade (1480.08), statin pathway (408.90), proteasome degradation (378.24)

2: Complement and coagulation cascades (546.42), proteasome (225.26), cholesterol metabolism (195.08)

Chylomicron remodeling (2106.52), nitric oxide-mediated signal transduction (1008.13), fibrinolysis (921.53), proteasomal ubiquitin-independent protein catabolic process (528.58), interleukin-1-mediated signaling pathway (209.32)

1: HNF4A (14.55), AR (13.99), NANOG (13.59)

2: PPARA (273.66)

3: FOXA2 (29.83), NR2C2 (25.90), HNF4G (24.99)

Skin:

early-HD vs. control

1: Translation factors (337.17), mRNA processing (261.60), methylation pathways (234.97)

2: Spliceosome (298.11), arginine biosynthesis (167.83), tyrosine metabolism (72.16)

Protein localization to cytoplasmic stress granule (356.98), mRNA splicing, via spliceosome (343.79), IRES-dependent viral translational initiation (198.37), aspartate family amino acid metabolic process (198.37), nucleoside metabolic process (198.37)

1: XRN2 (23.62), AR (23.21), TP63 (22.90)

2: BRCA1 (34.50), VDR (21.17), AR (14.95)

3: NELFE (93.56), KAT2A (74.77), TAF7 (48.19)

Skin:

early-HD vs. pre-HD

1: Extracellular vesicle-mediated signaling in recipient cells (1346.70), ErbB signaling pathway (298.26), AGE/RAGE pathway (176.44)

2: ErbB signaling pathway (327.55), oxytocin signaling pathway (295.74), neurotrophin signaling pathway (205.61)

Cargo loading into COPII-coated vesicle (1787.10), ERBB2 signaling pathway (942.71), ephrin receptor signaling pathway (130.95), Fc receptor signaling pathway (111.42), mRNA splicing, via spliceosome (65.83)

1: SOX11 (22.22), EGR1 (22.10), FOXP2 (19.42)

2: TP53 (130.54), SP1 (9.04)

3: TEAD4 (60.02), GTF3C2 (23.76), SP2 (20.43)

  1. Ontology enrichment using the Enrichr website. See the “Methods” section for details. Only non-redundant, aggregated terms are shown. Only entries of human samples in the databases were considered. Only terms that applied to at least two dysregulated proteins were considered. The combined score is shown in brackets. Only entries with a combined score of 5 or greater were considered. Top three terms for pathways and regulators and top 5 terms for ontology are shown